Men, Fertility, and Cancer
Men who confront a cancer diagnosis before beginning or completing their families may have many questions about how cancer treatment will affect their ability to have children in the future. The good...
View ArticleZevalin Plus Nonmyeloablative Allogeneic Transplantation Effective in...
The addition of Zevalin® (ibritumomab tiuxetan) to nonmyeloablative allogeneic transplantation (NMAT) is safe and produces early responses and prolonged disease control in high-risk patients with...
View ArticleCeliac Disease Associated with Higher Risk of Lymphoma
Individuals with celiac disease have an increased risk of lymphoma, particularly if they have a condition known as persistent villous atrophy, according to the results of a large cohort study published...
View ArticleAdding Revlimid to R-CHOP May Improve Outomes of Selected Patients with NHL
The results of a recently completed study reported in the Journal of Clinical Oncology indicate that the addition of Revlimid® (lenalidomide) to R-CHOP the standard treatment for non hodgkin lymphoma...
View ArticleClik here to view.
September Is National Blood Cancer Awareness Month
Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of blood cancer educational programs for national blood cancer awareness month. As the month of September brings blood...
View ArticleHIV-Positive Patients with Lymphoma Should No Longer be Excluded From...
CancerConnect News: HIV-positive patients with lymphoma were previously excluded from receiving autologous blood stem cell transplants as treatment, because of concern that these patients’ compromised...
View ArticleFDA Grants Fast Track Designation to SGX301 for First-Line Treatment of...
The U. S. Food and Drug Administration has granted Fast Track designation the synthetic hypericin (SGX301) development program for the first-line treatment of cutaneous T-cell lymphoma. Fast Track...
View ArticleWhat’s New in the Management of Lymphoma?
What’s New in the Management of Lymphoma? Cancers that begin in cells of the lymph system are referred to as malignant lymphomas. Lymphomas range from aggressive to slow growing or indolent and can be...
View ArticlePass it On: It’s Leukemia and Lymphoma National Awareness Month
Leukemia and lymphoma are both hematologic malignancies, meaning that they involve the blood or bone marrow. The American Cancer Society […] The post Pass it On: It’s Leukemia and Lymphoma National...
View ArticleThe First CAR-T Therapy Heading to the FDA
Kite Pharma reported that its CAR-T therapy demonstrated a 39% response rate, including a 33% complete response rate, in patients […] The post The First CAR-T Therapy Heading to the FDA appeared first...
View Article
